Bli medlem
Bli medlem

Du är här


Revenio Group Corporation: New CEO for Revenio and expansion in Management Team

Revenio Group Corporation, Stock Exchange Release, May 16, 2016 at 13:00


Revenio Group Plc.'s long term CEO Olli-Pekka Salovaara (born 1960) will leave
his position after a transition period on January 1st, 2017 and he will
continue in the position of Executive Chairman of the Board of Icare USA

Revenio Group Plc.'s Board of Directors has appointed M.Sc. Timo Hildén (born
1959) as the new Group CEO as of January 1st, 2017. Hildén has worked as the
CEO of Revenio Group's subsidiary Icare Finland since April 2012. Hildén has
also been appointed as the Segment Director of Revenio Health Tech as of May
16th, 2016.

"The strategy change we started in 2012 has progressed to the implementation
phase under Olli-Pekka Salovaara's lead and our organization is now in place
to support the set global growth objectives. Now is a good time to transfer
the position of CEO to Timo Hildén who is a strong expert in the health
technology sector. The transition period will ensure the successful
implementation of the change. It is very natural that Olli-Pekka will take
the responsibility of further embodiment of our US strategy since he is
already living in the United States. On behalf of the entire Board of
Directors I wish to express our thanks already at this stage to Olli-Pekka
for the job well done," saysPekka Tammela
, Chairman of the Board, Revenio Group Plc.

"During my term of office, we have transformed a conglomerate into a
successful health tech company which has resulted the growth of Revenio's
market value from some tens of millions to 200 million euros. I have worked
as the CEO of Revenio almost for ten eventful years. The decision to ease
the work burden as of next year has matured gradually. Timo Hildén who has
successfully managed Icare Finland, is the right person to continue the work
from here on," statesOlli-Pekka Salovaara

The Management Team of Revenio Group will be expanded as of June 1st, 2016 and
the members will be Revenio Group Plc's CEOOlli-Pekka Salovaara
(until December 31, 2016), Icare Finland Ltd's CEO and Segment Director of
Revenio Health Tech Timo Hilden
, Revenio Group Plc's CFORobin Pulkkinen
, Sales and Marketing DirectorTomi Karvo
, Revenio Research Oy's R&D DirectorAri Kukkonen
and Icare Finland Ltd's Operations DirectorAri Isomäki
as a new member. Also,Tiina Olkkonen
is attending Management Team meetings as an external communication specialist
and Management Team secretary. In addition, an Extended Management Team that
meets on quarterly basis is established as of June 1st, 2016, consisting of
Management Team members and the CEO of Icare USA IncJohn Floyd

For further information, please contact:
Chairman of the Board, Pekka Tammela
Tel: +358 40 503 9009

Nasdaq Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media

The Revenio Group in brief

Revenio is a Finnish, globally operating health technology corporation whose
worldwide success is based on a strongly patented intraocular pressure
measurement technology. The Revenio Group consists of Icare Finland Oy,
Revenio Research Oy and Oscare Medical Oy, in which Revenio holds a 53%
interest. The common denominators of Revenio's business operations include
screening, follow-up and the global need to make cost savings through
preventive health care. Revenio seeks vigorous growth in health technology.
Revenio aims at developing even more efficient and easily adopted methods for
the early-stage detection of diseases with significance for public health.
The focus of Revenio's screening technology is on the early detection of
glaucoma, osteoporosis, skin cancer and asthma, and the monitoring of these
during the treatment process.

In 2015, the Revenio Group's net sales totaled MEUR 20.3, with its operating
margin for continuing operations standing at 28.4%. Revenio Group Corporation
is listed on Nasdaq Helsinki.


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Revenio Group Corporation via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.